India

Coronavirus India Live Updates: Bharat Biotech’s ‘pre-submission’ meeting for Covaxin EUL with WHO today – The Indian Express

Beneficiaries at a vaccination center in Karave Gaon Health Post in Navi Mumbai.

Coronavirus India Live Updates: Hyderabad-based pharmaceutical company Bharat Biotech is set to meet with the World Health Organization (WHO), where it is expected to submit its proposal for an Emergency Use Listing of the Covaxin vaccine. The EUL would make it easier for Covaxin — developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) — to receive recognition in other countries where it has not received regulatory approvals.

India reported 50,581 new coronavirus cases in the last 24 hours, according to data released by the Union Health Ministry. The active caseload has dropped to 6,43,194, lowest in 82 days. The national recovery rate has risen to 96.56 per cent. With 1,358 new deaths, the country’s death toll surged to 3.9 lakh.

Meanwhile, revised data from the Union Health Ministry showed 88.09 lakh doses of Covid-19 vaccines were administered on the record-breaking Monday and that 64 per cent of the vaccinations took place in rural areas. That is three out of every five shots administered. 

In other news, the Delta Plus variant of the novel coronavirus, so far detected in three states in the country, has been categorised as a variant of concern by the Union Health Ministry. States have been directed to take up immediate containment measures in clusters where the variant has been detected.

Taking a jab at the Central government for the dip in vaccination figures, after an all-time high on Monday, Congress leader P Chidambaram said: “Hoard on Sunday, vaccinate on Monday, and go back to limping on Tuesday.” 

“That is the secret behind the world “record” of vaccinations on a ‘single day’,” he tweeted. 

On Monday, the Supreme Court reserved its verdict on a petition by two advocates seeking compensation of Rs 4 lakh to the kin of those who have died of Covid-19 or related complications. The Centre had submitted by affidavit on Saturday that state governments cannot afford to pay this, and had argued in favour of a broader approach including health interventions.

What are the provisions for compensation for death?

Last year, the Centre declared Covid-19 as a notified disaster under the Disaster Management Act.

Section 12(iii) of the Act says the National Authority shall recommend guidelines for the minimum standards of relief to be provided to persons affected by disaster, which shall include “ex gratia assistance on account of loss of life as also assistance on account of damage to houses and for restoration of means of livelihood”. Read the full explainer here. 

India reported 40 cases of Delta Plus variant of the novel coronavirus. Most of the cases were found in Maharashtra, Madhya Pradesh, Kerala and Tamil Nadu. It is still a variant of interest, government sources told ANI. 

A single dose of Covid 19 vaccine is effective in preventing deaths, according to a new analysis by the Indian Council of Medical Research-National Institute of Epidemiology (ICMR-NIE).Vaccine effectiveness in preventing Covid-19 deaths with one and two doses was 82 per cent and 95 per cent respectively.

The study ‘Covid-19 vaccine effectiveness in preventing deaths among high-risk groups in Tamil Nadu, India’, was published in the Indian Journal of Medical Research on June 21. The Tamil Nadu police department has been documenting vaccination of its workforce (as aggregate numbers with 0, 1 and 2 vaccine doses), and Covid-19 deaths during the second wave, along with details of the date of hospitalisation and vaccination. Read the full report here. 

Among those who took the second dose of the Covid-19 vaccine at the Rajiv Gandhi e-learning School in Pune on Tuesday was 96-year-old Mugatlal Shah. “Now, I am fully vaccinated and hope to complete a century,” said the retired businessman.

During the first Covid-19 wave in August and September last year, Shah’s son, daughter-in-law and grand-children had contracted the infection. “My father didn’t get infected… after we all recovered, we decided to take the vaccine on a priority basis,” said his son Raju Shah (63).

“At this age too, it is remarkable that he has not had a major illness… it would not be untrue to say that this is just one of the rare times that he has taken an injection. He didn’t complain of headache or side-effects post the first Covid-19 vaccine dose on March 27 at the Janta Vasahat vaccination clinic at Parvati,” he added. Read the full report here. 

While the test positivity rate for Covid-19 has decreased in most districts of Andhra Pradesh, the rise in the number of black fungus cases has left officials in the state worried. The state has registered 2,772 black fungus cases so far, of which 922 needed surgery. 

During a review meeting on Tuesday, Chief Minister Y S Jagan Mohan Reddy said extra precautions need to be taken as the lockdown imposed in neighbouring states is being relaxed, and inter-state migration has resumed. 

In many of the black fungus cases, an eye or portion of the jaw had to be removed to prevent the fungus from causing more damage. While 212 patients died, 1,232 have recovered and have been discharged. Read the full report here. 

India reported 50,848 new coronavirus cases in the last 24 hours, according to data released by the Union Health Ministry. The active caseload has dropped to 6,43,194, lowest in 82 days. The national recovery rate has risen to 96.56 per cent. With 1,358 new deaths, the country’s death toll surged to 3.9 lakh.

Hyderabad-based pharmaceutical company Bharat Biotech is set to meet with the World Health Organization (WHO), where it is expected to submit its proposal for an Emergency Use Listing of the Covaxin vaccine.

The EUL would make it easier for Covaxin — developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) — to receive recognition in other countries where it has not received regulatory approvals.

This comes a day after the much-awaited phase 3 trial results of the vaccine were released, according to which, Covaxin showed the ability to bring down symptomatic Covid-19 cases by 77.80 per cent. 

India reported 42,640 new Covid-19 cases, which is the lowest in 91 days, and 1,167 deaths, the lowest since April 14, on Tuesday, as per the Union Health Ministry. The number of fresh cases reported on Tuesday are 134 in Delhi, 570 in Mumbai, 803 in Bengaluru, 172 in Kolkata and 410 in Chennai.

Referring to the record 82.7 lakh vaccinations done on June 21, the government earlier on Tuesday said that nearly 64 per cent of the jabs were given in rural areas. Addressing a joint press conference on the pandemic situation and vaccination status, the official said, “A historic milestone was achieved on 21st June 2021–88.09 lakh doses administered in a single day.” Of the doses, 36.32 per cent were administered in urban areas and 63.68 per cent in rural areas, the official added.

Meanwhile, the Pfizer CEO said that Pfizer vaccine is in the final stages of getting approval for use in India, news agency ANI reported.

In other news, Congress leader Rahul Gandhi Tuesday released a white paper on Covid-19 saying “its aim is not finger-pointing at the government but to help the nation prepare for the third wave of infection. The whole country knows that a third wave will strike.”

Leave a Comment

Your email address will not be published.

You may also like